866-997-4948(US-Canada Toll Free)

EMEA (Europe,Middle East and Africa) Fidaxomicin Market Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 106 Pages

In this report, the EMEA Fidaxomicin market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Tablets), revenue (Million USD), market share and growth rate of Fidaxomicin for these regions, from 2013 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Fidaxomicin market competition by top manufacturers/players, with Fidaxomicin sales volume (K Tablets), price (USD/ Tablets), revenue (Million USD) and market share for each manufacturer/player; the top players including
Astellas
Merck
...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Purity:90%
Purity:95%
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Retail Pharmacies

Table of Contents

EMEA (Europe, Middle East and Africa) Fidaxomicin Market Report 2018
1 Fidaxomicin Overview
1.1 Product Overview and Scope of Fidaxomicin
1.2 Classification of Fidaxomicin
1.2.1 EMEA Fidaxomicin Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 EMEA Fidaxomicin Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Purity:90%
1.2.4 Purity:95%
1.2.5 Others
1.3 EMEA Fidaxomicin Market by Application/End Users
1.3.1 EMEA Fidaxomicin Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Retail Pharmacies
1.4 EMEA Fidaxomicin Market by Region
1.4.1 EMEA Fidaxomicin Market Size (Value) Comparison by Region (2013-2025)
1.4.2 Europe Status and Prospect (2013-2025)
1.4.3 Middle East Status and Prospect (2013-2025)
1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Fidaxomicin (2013-2025)
1.5.1 EMEA Fidaxomicin Sales and Growth Rate (2013-2025)
1.5.2 EMEA Fidaxomicin Revenue and Growth Rate (2013-2025)

2 EMEA Fidaxomicin Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Fidaxomicin Market Competition by Players/Manufacturers
2.1.1 EMEA Fidaxomicin Sales Volume and Market Share of Major Players (2013-2018)
2.1.2 EMEA Fidaxomicin Revenue and Share by Players (2013-2018)
2.1.3 EMEA Fidaxomicin Sale Price by Players (2013-2018)
2.2 EMEA Fidaxomicin (Volume and Value) by Type/Product Category
2.2.1 EMEA Fidaxomicin Sales and Market Share by Type (2013-2018)
2.2.2 EMEA Fidaxomicin Revenue and Market Share by Type (2013-2018)
2.2.3 EMEA Fidaxomicin Sale Price by Type (2013-2018)
2.3 EMEA Fidaxomicin (Volume) by Application
2.4 EMEA Fidaxomicin (Volume and Value) by Region
2.4.1 EMEA Fidaxomicin Sales and Market Share by Region (2013-2018)
2.4.2 EMEA Fidaxomicin Revenue and Market Share by Region (2013-2018)
2.4.3 EMEA Fidaxomicin Sales Price by Region (2013-2018)

3 Europe Fidaxomicin (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Fidaxomicin Sales and Value (2013-2018)
3.1.1 Europe Fidaxomicin Sales Volume and Growth Rate (2013-2018)
3.1.2 Europe Fidaxomicin Revenue and Growth Rate (2013-2018)
3.2 Europe Fidaxomicin Sales and Market Share by Type
3.3 Europe Fidaxomicin Sales and Market Share by Application
3.4 Europe Fidaxomicin Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Fidaxomicin Sales Volume by Countries (2013-2018)
3.4.2 Europe Fidaxomicin Revenue by Countries (2013-2018)
3.4.3 Germany Fidaxomicin Sales and Growth Rate (2013-2018)
3.4.4 France Fidaxomicin Sales and Growth Rate (2013-2018)
3.4.5 UK Fidaxomicin Sales and Growth Rate (2013-2018)
3.4.6 Russia Fidaxomicin Sales and Growth Rate (2013-2018)
3.4.7 Italy Fidaxomicin Sales and Growth Rate (2013-2018)
3.4.8 Benelux Fidaxomicin Sales and Growth Rate (2013-2018)

4 Middle East Fidaxomicin (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Fidaxomicin Sales and Value (2013-2018)
4.1.1 Middle East Fidaxomicin Sales Volume and Growth Rate (2013-2018)
4.1.2 Middle East Fidaxomicin Revenue and Growth Rate (2013-2018)
4.2 Middle East Fidaxomicin Sales and Market Share by Type
4.3 Middle East Fidaxomicin Sales and Market Share by Application
4.4 Middle East Fidaxomicin Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Fidaxomicin Sales Volume by Countries (2013-2018)
4.4.2 Middle East Fidaxomicin Revenue by Countries (2013-2018)
4.4.3 Saudi Arabia Fidaxomicin Sales and Growth Rate (2013-2018)
4.4.4 Israel Fidaxomicin Sales and Growth Rate (2013-2018)
4.4.5 UAE Fidaxomicin Sales and Growth Rate (2013-2018)
4.4.6 Iran Fidaxomicin Sales and Growth Rate (2013-2018)

5 Africa Fidaxomicin (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Fidaxomicin Sales and Value (2013-2018)
5.1.1 Africa Fidaxomicin Sales Volume and Growth Rate (2013-2018)
5.1.2 Africa Fidaxomicin Revenue and Growth Rate (2013-2018)
5.2 Africa Fidaxomicin Sales and Market Share by Type
5.3 Africa Fidaxomicin Sales and Market Share by Application
5.4 Africa Fidaxomicin Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Fidaxomicin Sales Volume by Countries (2013-2018)
5.4.2 Africa Fidaxomicin Revenue by Countries (2013-2018)
5.4.3 South Africa Fidaxomicin Sales and Growth Rate (2013-2018)
5.4.4 Nigeria Fidaxomicin Sales and Growth Rate (2013-2018)
5.4.5 Egypt Fidaxomicin Sales and Growth Rate (2013-2018)
5.4.6 Algeria Fidaxomicin Sales and Growth Rate (2013-2018)

6 EMEA Fidaxomicin Manufacturers/Players Profiles and Sales Data
6.1 Astellas
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Fidaxomicin Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Astellas Fidaxomicin Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Fidaxomicin Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Fidaxomicin Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
...

7 Fidaxomicin Manufacturing Cost Analysis
7.1 Fidaxomicin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Fidaxomicin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Fidaxomicin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Fidaxomicin Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Fidaxomicin Market Forecast (2018-2025)
11.1 EMEA Fidaxomicin Sales, Revenue and Price Forecast (2018-2025)
11.1.1 EMEA Fidaxomicin Sales and Growth Rate Forecast (2018-2025)
11.1.2 EMEA Fidaxomicin Revenue and Growth Rate Forecast (2018-2025)
11.1.3 EMEA Fidaxomicin Price and Trend Forecast (2018-2025)
11.2 EMEA Fidaxomicin Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Fidaxomicin Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Fidaxomicin Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Fidaxomicin Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Fidaxomicin Sales Forecast by Type (2018-2025)
11.7 EMEA Fidaxomicin Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Fidaxomicin
Figure EMEA Fidaxomicin Sales Volume (K Tablets) by Type (2013-2025)
Figure EMEA Fidaxomicin Sales Volume Market Share by Type (Product Category) in 2017
Figure Purity:90% Product Picture
Figure Purity:95% Product Picture
Figure Others Product Picture
Figure EMEA Fidaxomicin Sales Volume (K Tablets) by Application (2013-2025)
Figure EMEA Sales Market Share of Fidaxomicin by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure EMEA Fidaxomicin Market Size (Million USD) by Region (2013-2025)
Figure Europe Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Fidaxomicin Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Fidaxomicin Revenue (Million USD) Status and Forecast by Countries
Figure Africa Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Fidaxomicin Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Fidaxomicin Sales Volume and Growth Rate (2013-2025)
Figure EMEA Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Fidaxomicin Market Major Players Product Sales Volume (K Tablets) (2013-2018)
Table EMEA Fidaxomicin Sales Volume (K Tablets) of Major Players (2013-2018)
Table EMEA Fidaxomicin Sales Share by Players (2013-2018)
Figure 2017 Fidaxomicin Sales Share by Players
Figure 2017 Fidaxomicin Sales Share by Players
Figure EMEA Fidaxomicin Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Fidaxomicin Revenue (Million USD) by Players (2013-2018)
Table EMEA Fidaxomicin Revenue Share by Players (2013-2018)
Table 2017 EMEA Fidaxomicin Revenue Share by Players
Table 2017 EMEA Fidaxomicin Revenue Share by Players
Table EMEA Fidaxomicin Sale Price (USD/ Tablets) by Players (2013-2018)
Table EMEA Fidaxomicin Sales (K Tablets) and Market Share by Type (2013-2018)
Table EMEA Fidaxomicin Sales Share by Type (2013-2018)
Figure Sales Market Share of Fidaxomicin by Type (2013-2018)
Figure EMEA Fidaxomicin Sales Market Share by Type (2013-2018)
Table EMEA Fidaxomicin Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Fidaxomicin Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Fidaxomicin by Type in 2017
Table EMEA Fidaxomicin Sale Price (USD/ Tablets) by Type (2013-2018)
Table EMEA Fidaxomicin Sales (K Tablets) and Market Share by Application (2013-2018)
Table EMEA Fidaxomicin Sales Share by Application (2013-2018)
Figure Sales Market Share of Fidaxomicin by Application (2013-2018)
Figure EMEA Fidaxomicin Sales Market Share by Application in 2017
Table EMEA Fidaxomicin Sales (K Tablets) and Market Share by Region (2013-2018)
Table EMEA Fidaxomicin Sales Share by Region (2013-2018)
Figure Sales Market Share of Fidaxomicin by Region (2013-2018)
Figure EMEA Fidaxomicin Sales Market Share in 2017
Table EMEA Fidaxomicin Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Fidaxomicin Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Fidaxomicin by Region (2013-2018)
Figure EMEA Fidaxomicin Revenue Market Share Regions in 2017
Table EMEA Fidaxomicin Sales Price (USD/ Tablets) by Region (2013-2018)
Figure Europe Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Europe Fidaxomicin Revenue and Growth Rate (2013-2018)
Table Europe Fidaxomicin Sales (K Tablets) by Type (2013-2018)
Table Europe Fidaxomicin Market Share by Type (2013-2018)
Figure Europe Fidaxomicin Market Share by Type in 2017
Table Europe Fidaxomicin Sales (K Tablets) by Application (2013-2018)
Table Europe Fidaxomicin Market Share by Application (2013-2018)
Figure Europe Fidaxomicin Market Share by Application in 2017
Table Europe Fidaxomicin Sales (K Tablets) by Countries (2013-2018)
Table Europe Fidaxomicin Sales Market Share by Countries (2013-2018)
Figure Europe Fidaxomicin Sales Market Share by Countries (2013-2018)
Figure Europe Fidaxomicin Sales Market Share by Countries in 2017
Table Europe Fidaxomicin Revenue (Million USD) by Countries (2013-2018)
Table Europe Fidaxomicin Revenue Market Share by Countries (2013-2018)
Figure Europe Fidaxomicin Revenue Market Share by Countries (2013-2018)
Figure Europe Fidaxomicin Revenue Market Share by Countries in 2017
Figure Germany Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure France Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure UK Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Russia Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Italy Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Benelux Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Middle East Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Middle East Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Fidaxomicin Sales (K Tablets) by Type (2013-2018)
Table Middle East Fidaxomicin Market Share by Type (2013-2018)
Figure Middle East Fidaxomicin Market Share by Type (2013-2018)
Table Middle East Fidaxomicin Sales (K Tablets) by Applications (2013-2018)
Table Middle East Fidaxomicin Market Share by Applications (2013-2018)
Figure Middle East Fidaxomicin Sales Market Share by Application in 2017
Table Middle East Fidaxomicin Sales Volume (K Tablets) by Countries (2013-2018)
Table Middle East Fidaxomicin Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Fidaxomicin Sales Volume Market Share by Countries in 2017
Table Middle East Fidaxomicin Revenue (Million USD) by Countries (2013-2018)
Table Middle East Fidaxomicin Revenue Market Share by Countries (2013-2018)
Figure Middle East Fidaxomicin Revenue Market Share by Countries (2013-2018)
Figure Middle East Fidaxomicin Revenue Market Share by Countries in 2017
Figure Saudi Arabia Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Israel Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure UAE Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Iran Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Africa Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Africa Fidaxomicin Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Fidaxomicin Sales (K Tablets) by Type (2013-2018)
Table Africa Fidaxomicin Sales Market Share by Type (2013-2018)
Figure Africa Fidaxomicin Sales Market Share by Type (2013-2018)
Figure Africa Fidaxomicin Sales Market Share by Type in 2017
Table Africa Fidaxomicin Sales (K Tablets) by Application (2013-2018)
Table Africa Fidaxomicin Sales Market Share by Application (2013-2018)
Figure Africa Fidaxomicin Sales Market Share by Application (2013-2018)
Table Africa Fidaxomicin Sales Volume (K Tablets) by Countries (2013-2018)
Table Africa Fidaxomicin Sales Market Share by Countries (2013-2018)
Figure Africa Fidaxomicin Sales Market Share by Countries (2013-2018)
Figure Africa Fidaxomicin Sales Market Share by Countries in 2017
Table Africa Fidaxomicin Revenue (Million USD) by Countries (2013-2018)
Table Africa Fidaxomicin Revenue Market Share by Countries (2013-2018)
Figure Africa Fidaxomicin Revenue Market Share by Countries (2013-2018)
Figure Africa Fidaxomicin Revenue Market Share by Countries in 2017
Figure South Africa Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Nigeria Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Egypt Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Algeria Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Table Astellas Fidaxomicin Basic Information List
Table Astellas Fidaxomicin Sales (K Tablets), Revenue (Million USD), Price (USD/ Tablets) and Gross Margin (2013-2018)
Figure Astellas Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Astellas Fidaxomicin Sales Market Share in EMEA (2013-2018)
Figure Astellas Fidaxomicin Revenue Market Share in EMEA (2013-2018)
Table Merck Fidaxomicin Basic Information List
Table Merck Fidaxomicin Sales (K Tablets), Revenue (Million USD), Price (USD/ Tablets) and Gross Margin (2013-2018)
Figure Merck Fidaxomicin Sales (K Tablets) and Growth Rate (2013-2018)
Figure Merck Fidaxomicin Sales Market Share in EMEA (2013-2018)
Figure Merck Fidaxomicin Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fidaxomicin
Figure Manufacturing Process Analysis of Fidaxomicin
Figure Fidaxomicin Industrial Chain Analysis
Table Raw Materials Sources of Fidaxomicin Major Manufacturers in 2017
Table Major Buyers of Fidaxomicin
Table Distributors/Traders List
Figure EMEA Fidaxomicin Sales (K Tablets) and Growth Rate Forecast (2018-2025)
Figure EMEA Fidaxomicin Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Fidaxomicin Price (USD/ Tablets) and Trend Forecast (2018-2025)
Table EMEA Fidaxomicin Sales (K Tablets) Forecast by Region (2018-2025)
Figure EMEA Fidaxomicin Sales Market Share Forecast by Region (2018-2025)
Table EMEA Fidaxomicin Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Fidaxomicin Revenue Market Share Forecast by Region (2018-2025)
Table Europe Fidaxomicin Sales (K Tablets) Forecast by Countries (2018-2025)
Figure Europe Fidaxomicin Sales Market Share Forecast by Countries (2018-2025)
Table Europe Fidaxomicin Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Fidaxomicin Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Fidaxomicin Sales (K Tablets) Forecast by Countries (2018-2025)
Figure Middle East Fidaxomicin Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Fidaxomicin Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Fidaxomicin Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Fidaxomicin Sales (K Tablets) Forecast by Countries (2018-2025)
Figure Africa Fidaxomicin Sales Market Share Forecast by Countries (2018-2025)
Table Africa Fidaxomicin Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Fidaxomicin Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Fidaxomicin Sales (K Tablets) Forecast by Type (2018-2025)
Figure EMEA Fidaxomicin Sales Market Share Forecast by Type (2018-2025)
Table EMEA Fidaxomicin Sales (K Tablets) Forecast by Application (2018-2025)
Figure EMEA Fidaxomicin Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *